Trials / Completed
CompletedNCT03293225
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
A Randomized Open Labeled Trial to Compare the Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist in Patients With Chronic Urticaria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria
Detailed description
* For four weeks * After the researcher confirms the selection / exclusion criteria on the baseline, the UAS, K-UCT, and CU-QoL are created and randomized from the subject. * Receive UAS, K-UCT, and CU-QoL from the subject during the last visit to assess safety
Conditions
Timeline
- Start date
- 2017-08-24
- Primary completion
- 2019-05-24
- Completion
- 2019-05-24
- First posted
- 2017-09-26
- Last updated
- 2019-07-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03293225. Inclusion in this directory is not an endorsement.